  Alzheimer's disease (AD) is a neurodegenerative disorder and the most common
cause of dementia in the elderly. The extracellular accumulation of
amyloid-$\beta$ (A$\beta$) in senile plaques is a principal event in the
pathogenesis and there is growing evidence that the dysregulation of lipid
pathways is implicated in the disease, however the link between these two is
still under study. In this work, we investigated human brain samples, from 11
AD patients and a control cohort of age-matched subjects without AD, using
label-free chemically-specific Raman micro-spectroscopy. The collected image
data were quantitatively analysed using an efficient quantitative
unsupervised/partially supervised non-negative matrix factorization method, to
retrieve the concentration maps and spectra of the samples' chemical
constituents. Significant changes in lipid composition as well as increased
concentrations of oxidative stress bio-markers were observed in AD tissues
compared to the control. In particular, the analysis revealed accumulations of
cholesteryl esters with saturated long-chain fatty acids (FAs), A$\beta$
fibrils, arachidic acid, fibrin, collagen-like amyloidogenic component (CLAC),
$\beta$-carotene and magnetite, co-localising in A$\beta$ plaques of AD human
brains and exhibiting concentrations highest at the fibrillar core and lowest
at the rim. This finding opens perspectives for new anti-inflammatory and
antioxidant drug strategies, designed to restore brain homeostasis as potential
therapeutics of AD. We also demonstrate by the means of spatial concentration
histograms that these identified species separate AD from non-demented control
brains, beneficial for AD diagnosis.
